Abstract
Asthma is a chronic inflammatory disorder of the airways characterized by an obstruction of airflow. It affects people of all ages and is characterized by repeated attacks of difficulty in breathing. Airway inflammation may cause recurrent or persistent bronchospasm, wheezing, breathlessness, tightness in the chest and coughing, particularly at night, in the early morning, or after exercise.
Chapter PDF
References
Brenner BE. Bronchial asthma in adults: presentation to the emergency department. Part I: Pathogenesis, clinical manifestations, diagnostic evaluation, and differential diagnosis. Am J Emerg Med 1983; 1:50–70
Brenner BE. Bronchial asthma in adults: presentation to the emergency department. Part II: Sympathomimetics, respiratory failure, recommendations for initial treatment, indications for admission, and summary. Am J Emerg Med 1983b; 1:306–33
FitzGerald JM, Macklem P. Proceedings of a workshop on near fatal asthma. Can Respir J 1995; 2:113–26
Williams TJ. Risks factors for morbidity in mechanically ventilated patients with acute severe asthma. Am Rev Respir Dis 1992; 146(3):607–615
DeNicola LK. Treatment of critical status asthmaticus in children. Pediatric Crit Care 1994; 41(6): 1293–1324
McFadden ER Jr, Warren EL. Observations on asthma mortality. Ann Intern Med 1997; 127(2): 142–7
Newcomb R. Respiratory failure from asthma. A marker for children with high morbidity and mortality. Am J Dis Child. 1988; 142(10):1041–1044
Spitzer WO. The use of b-agonist and the risk of death and near death from asthma. N Engl J Med 1992; 326(8):501–506
Tobin MJ. Asthma, airway biology, and nasal disorders in AJRCCM 2001. Am J Respir Crit Care Med 2002; 165:598–618
Hohlfeld JM, Ahlf K, Enhorning G, et al. Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge. Am J Respir Crit Care Med 1999; 159:1803–1809
Hohlfeld JM. The role of surfactant in asthma. Respir Res 2002; 3:4–12
Kurashima K, Fujimura M, Tsujiura M, Matsuda T. Effect of surfactant inhalation on allergic bronchocontriction in guinea pigs. Clin Exp Allergy 1997, 27:337–342
British Thoracic Society, et al. Guidelines for the management of asthma: a summary. BMJ. 1993 Mar 20; 306(6880):776–782
Huber P et le Groupe Francophone de Réanimation Pédiatrique. Les asthmes aigus graves en reanimation pediatrique. ArchPediatr 1994; 1:346–349
Corbridge TC. The assessment and management of adults with status asthmaticus. Am J Respir Crit Care Med 1995; 151(5): 1296–1316
Downes JJ. Arterial blood gas analysis and acid base desorders in infants and children with status asthmaticus. Pediatrics 1968; 42(2):238–249
Hoonig EG. Chronic obstructive pulmonary disease and asthma. In: Handbook of Mechanical ventilation support. Ed: Perel A and Stock MC. Williams & Wilkins, Baltimore. 1992; pp 227–245
Kurth CD. Obstructive airway diseases in infants and children. In: Neonatal and Pediatric Respiratory Care. Beck Koff Eitzman and Neu. 2nd Edition. Mosby, St Louis. 1993; 102–127
Jain S. Ventilation of patients with asthma and obstructive lung disease. Critical Care Clinics 1998; 14(4):685–705
Cox RG. Efficacy, results and complications of mechanical ventilation in children with status asthmaticus. Pediatr Pulmonol 1991; 11:120–126
Marraro G. Airway management. In Bissonnette B, Dalens BJ eds. “Principles and practice of pediatric anesthesia” McGraw-Hill Comp. New York 2001; pp778–814
Tuxen DV. The effects of ventilatory pattern on hyperinflation, airway pressures and circulation in mechanical ventilation of patients with severe air-flow obstruction. Am Rev Respir Dis 1987; 136:872–879
Tuxen DV. Use of measurement of pulmonary hyperinflation to control the level of mechanical ventilation in patients with acute severe asthma. Am Rev Respir Dis 1992; 146:1136–1142
Slutsky AS. Mechanical ventilation. Chest 1993; 104:1833–1859
Darioli R. Mechanical controlled hypoventilation in status asthmaticus. Am Rev Respir Dis 1984; 129(3):385–387
Hicking K, Joyce C. Permissive hypercapnia in ARDS and its effect on tissue oxygenation. Acta Anaesthesiol Scand 1995; 39:201–208
Feihl F, Perret C. Permissive hypercapnia: how permissive should we be? Am J Respir Crit Care Med 1994; 150:1722–1737
Tuxen D. Permissive hypercapnia ventilation. Am J Respir Crit Care Med 1994; 150:870–874
Marraro G A. Innovative practices of ventilatory support with pediatric patients. Pediatric Critical Care Medicine 2003; 4(1): 8–20
Appel D, Karpel JP, Sherman M. Epinephrine improves expiratory flow rates in patients with asthma who do not respond to inhaled metaproterenol sulfate. J Allergy Clin Immunol 1989 Jul; 84(1): 90–98
Dreyfuss D, Saumon G. Ventilator-induced lung injury:lesson from experimental studies [State of the Art], Am J Respir Crit Care Med 1998; 157:294–330
Lachmann B. Open up the lung and keep the lung open. Intensive Care Med. 1992; 18(6):319–321
Qvist J. High-level PEEP in severe asthma. N Engl J Med 1982; 18:1347–1348
Shivaram U. Cardiopulmonary responses to continuous positive airway pressure in acute asthma. J Crit Care 1993; 8:87–92
Smith TC. Impact of PEEP on lung mechanics and work of breathing in severe airflow obstruction. J Appl Physiol 1988; 65:1488–1499
Ranieri VM. Physiologic effects of positive end-expiratory pressure in patients with chronic obstructive pulmonary disease during acute ventilatory failure and controlled mechanical ventilation. Am Rev Respir Dis 1993; 147:5–13
Bierman CW. Pneumomediastinum and pneumothorax complicating asthma in children. Am J Dis Child 1967; 114:43–47
Van der Touw T. Cardiorespiratory consequences of expiratory chest wall compression during mechanical ventilation and severe hyperinflation. Crit Care Med 1993; 21:1908–1914
Rock MJ. Use of ketamine in asthmatic children to treat respiratory failure refractory to conventional therapy. Crit Care Med 1986; 14(5):514–516
Strube PJ. Ketamine by continuous infusion in status asthmaticus. Anesthesia 1986; 41(10): 1087
L’Hommedieu CS, Arens JJ. The use of ketamine for the emergency intubation of patients with status asthmaticus. Ann Emerg Med 1987; 16:568–71
Bierman MI. Prolonged isoflurane anesthesia in status asthmaticus. Crit Care Med 1986; 14:832–833
Saulnier FF. Respiratory and hemodynamic effects of halothane in status asthmaticus. Intensive Care Med 1990;16:104–107
Bloch H, Silverman R, Mancherje N, et al. Intravenous magnesium sulfate as an adjunct in the treatment of acute asthma. Chest 1995; 107(6): 1576–81
Kass JE, Castriotta RJ. Heliox therapy in acute severe asthma. Chest 1995; 107:757–760
Downey P, Cox R.. Update on the management of status asthmaticus. Curr Opin Pediatr 1996; 8:226–233
Gluck EH, Onorato DJ, Castriotta R. Helium-oxygen mixtures in intubated patients with status asthmaticus and respiratory acidosis. Chest 1990; 98:693–698
Manthous CA, Hall JB, Caputo MA, et al. Heliox improves pulsus paradoxus and peak expiratory flow in non intubated patients with severe asthma. Am J Respir Crit Care Med 1995; 151:310–314
Rishani R, El-Khatib M, Mroueh S. Treatment of severe status asthmaticus with nitric oxide. Pediatr Pulmonol 1999; 28(6):451–453
Luchetti M, Casiraghi G, Valsecchi R, Marraro G. Porcine-derived surfactant treatment of severe bronchiolitis. Acta Anaesthesiol Scand 1998; 42(7):805–810
Luchetti M, Gallini C., Pigna A, et al. Multicenter, randomized, controlled study of porcine surfactant in severe respiratory syncytial virus-induced respiratory failure. Pediatric Critical Care Medicine 2002; 3(3): 261–268
Tibby SM, Hatherill M, Wright SM, et al. Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am J Resp Crit Care Med 2000; 162:1251–1256
Marraro GA. Surfactant use in severe bronchiolitis. Biol Neonate 2002; 81 (suppl 1):28
Kurashima K, Ogawa H, Ohka T, et al. A pilot study of surfactant inhalation in the treatment of asthmatic attack. Aerugi (Jpn J Allergol) 1991, 40:160–163
Heeley EL, Hohlfeld JM, Krug N, Postle AD. Phospholipid molecular species of bronchoalveolar lavage fluid after local allergen challenge in asthma. Am J Physiol (Lung Cell Mol Physiol) 2000, 278:L305-L311
Fuchimukai T, Fujiwara T, Takahashi A, Enhorning G. Artificial pulmonary surfactant inhibited by proteins. J Appl Physiol 1987, 62:429–437
Seeger W, Grube C., Günther A, Schmidt R. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 1993, 6:971–977
Liu M, Wang L, Li E, Enhorning G. Pulmonary surfactant given prophylactically alleviates an asthma attack in guinea-pigs. Clin Exp Allergy 1996, 26:270–275
King D. Extracorporeal membrane oxygenation as emergency treatment for life-threatening acute severe asthma. Postgraduate Med J 1986; 62:855–857
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media Dordrecht
About this paper
Cite this paper
Marraro, G.A. (2003). Treatment of Asthma Patients Under Severe Conditions. In: Gradoń, L., Marijnissen, J. (eds) Optimization of Aerosol Drug Delivery. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-0267-6_15
Download citation
DOI: https://doi.org/10.1007/978-94-017-0267-6_15
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-6436-3
Online ISBN: 978-94-017-0267-6
eBook Packages: Springer Book Archive